CD4 and type 1 diabetes mellitus: Our EU-tagging technique led to the identification of several tRFs delivered to beta cells upon adoptive transfer of activated CD4+/CD25− T cells from NOD.BDC 2.5 mice, a treatment known to trigger type 1 diabetes in the receiving NOD.SCID mice within a few days [38, 39, 41].